CDKN2A and head and neck squamous cell carcinoma: To the best of our knowledge based on PubMed and Medline databases, this is the first study to have analyzed the concentrations of CDKN2A and Ki-67 proteins in homogenates of tumors and matched surgical margins from patients with HNSCC using an immunoassay (ELISA).